Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The pathologic anatomy of the Taussig-Bing heart: riding pulmonary artery; report of a case.

Bulletin. International Association of Medical Museums·2014
Same author

Public health approach to detection of non-O157 Shiga toxin-producing Escherichia coli: summary of two outbreaks and laboratory procedures.

Epidemiology and infection·2011
Same author

Rapid laboratory diagnosis of diphtheria.

Bulletin of the U.S. Army Medical Department. United States. Army. Medical Department·2010
Same author

Pectin excretion studies in the human being.

The Journal of laboratory and clinical medicine·2010
Same author

Modifications of Mueller's medium for rapid diagnosis of C. diphtheriae.

American journal of clinical pathology·2010
Same author

Rabbit Pancreas in Protein Malnutrition (Experimental Kwashiorkor) and after Cortisone Administration.

The American journal of pathology·2009

Related Experiment Video

Updated: Jun 18, 2026

Characterizing Histone Post-translational Modification Alterations in Yeast Neurodegenerative Proteinopathy Models
08:33

Characterizing Histone Post-translational Modification Alterations in Yeast Neurodegenerative Proteinopathy Models

Published on: March 24, 2019

Neuronal Enzyme Alterations in Tay-Sachs Disease

S S Lazarus, B J Wallace, B W Volk

    The American Journal of Pathology
    |December 9, 2009
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Immunohistochemical Visualization of Hippocampal Neuron Activity After Spatial Learning in a Mouse Model of Neurodevelopmental Disorders
    07:43

    Immunohistochemical Visualization of Hippocampal Neuron Activity After Spatial Learning in a Mouse Model of Neurodevelopmental Disorders

    Published on: May 12, 2015

    Dynamic Clamp Methods to Investigate Impaired Neuronal Excitability Associated with Autism
    08:44

    Dynamic Clamp Methods to Investigate Impaired Neuronal Excitability Associated with Autism

    Published on: October 17, 2025

    Related Experiment Videos

    Last Updated: Jun 18, 2026

    Characterizing Histone Post-translational Modification Alterations in Yeast Neurodegenerative Proteinopathy Models
    08:33

    Characterizing Histone Post-translational Modification Alterations in Yeast Neurodegenerative Proteinopathy Models

    Published on: March 24, 2019

    Immunohistochemical Visualization of Hippocampal Neuron Activity After Spatial Learning in a Mouse Model of Neurodevelopmental Disorders
    07:43

    Immunohistochemical Visualization of Hippocampal Neuron Activity After Spatial Learning in a Mouse Model of Neurodevelopmental Disorders

    Published on: May 12, 2015

    Dynamic Clamp Methods to Investigate Impaired Neuronal Excitability Associated with Autism
    08:44

    Dynamic Clamp Methods to Investigate Impaired Neuronal Excitability Associated with Autism

    Published on: October 17, 2025